The U.S. Food and Drug Administration today issued a draft guidance encouraging food manufacturers to voluntarily declare sesame in the ingredient list on food labels.
On Oct. 30, 2018, the FDA issued a notice inviting data and information on the occurrence and severity of sesame allergies in the U.S. and the prevalence of sesame-containing foods in the U.S. that are not required to disclose sesame as an ingredient. While the exact frequency of sesame allergies in the U.S. is unknown, it is estimated in some recent studies to be more than 0.1%, which is similar to allergies to soy and fish. The responses that the FDA received indicated that some allergic reactions, such as hives, vomiting, wheezing and anaphylaxis, may be occurring from products with undeclared sesame or products that contain ingredients like tahini.
Additionally, the FDA continues to assess allergens of public health importance, including potential science-based options to empower consumers with information about these allergens.
The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.